Skip to main content
Press Enter
BASF offers the world's largest portfolio of chemical raw materials for the pharmaceutical industry, ensuring the needs of our partners are always met. Every step of biopharmaceutical manufacturing requires high-quality raw materials delivered through a transparent, sustainable supply chain. BASF Biopharma Ingredients is committed to meeting your requirements for every ingredient we supply to the biologics industry. At BASF, we create excipients that are safe, effective, and convenient for your customers. Whether you’re developing orally disintegrating formulations that require taste-masking or modified release tablets, BASF has ingredients to deliver the precision you need, every time. At BASF, we offer a comprehensive range of cutting-edge solubilization polymers, and have an unparalleled understanding of the corresponding process technologies. BASF offers an unparalleled portfolio of excipients for topical formulations, enabling you with the tools to overcome formulation challenges. With products based on over 150 years of industry experience, BASF is committed to maintaining the highest level of quality across the product spectrum.
View in MyProductWorld
MyProductWorld Your Product Assistant
Illustration of MyProductWorld Representative
View documentation
RegXcellence® Your Virtual Quality & Regulatory Assistant
Illustration of RegXcellence Representative
Try it in a Formulation
ZoomLab™ Your Virtual Formulation Assistant

Save time and money. Instantly predict your next formulation now!

K85EE Omega-3-acid ethylesters (K85EE) is a light-yellow liquid comprised of 430-495 mg/g eicosapentaenoic acid (EPA) and 347-403 mg/g docosahexaenoic acid (DHA). The content of EPA and DHA ethyl esters is 800-880 mg/g and the content of total omega-3-acid ethyl esters is a minimum of 90 per cent. Tocopherol is added as an antioxidant. K85EE is a highly concentrated, unsaturated oil. It oxidizes readily in contact with air and is, therefore, filled in drums purged with nitrogen. It is well suited for use in soft gelatin capsules as the sole fill material.


  • K85EE is used as an active ingredient in finished drug products according to a documented and approved indication after approval by the concerned medicinal authority. The exact indication may be different in different markets
  • Long history of use in the finished drug product Omacor®/Lovaza, the first FDA- and EU-approved omega-3-based prescription drug
  • Our sustainable sourcing and production contribute to reduction of our customers carbon footprint
  • The combination of technology and our know-how ensures an efficient production with a high utilization of the raw material

Technical Overview

Compendial Name

Omega-3-acid ethyl esters 90 (Ph.Eur.), Omega-3-Acid Ethyl Esters (USP)

Region of Manufacture


Package Size

  • 0,11KG Aluminium bottle
  • 190KG Steel drums

See all technical details about K85EE Omega-3-acid ethylesters - Japanese Market

MyProductWorld is your resource for technical details about BASF products